Lowry R P, Forbes R D, Blackburn J H, Marghesco D M
Transplantation. 1985 Nov;40(5):545-50.
The cellular requirements for rejection of heart grafts bearing isolated major histocompatibility complex (MHC) subregion RT1A-encoded class I disparities was assessed by adoptive transfer. Sublethally irradiated (780 rads) (PVG X WF)F1 recipients of irradiated PVG-RT1r1 heart grafts were selectively reconstituted with spleen cells from syngeneic donors previously sensitized with two sequential PVG-RT1r1 skin grafts. PVG-RT1r1 heart grafts were rejected acutely in recipients reconstituted with 10 X 10(6) unfractionated immune spleen cells (7-9 days, n = 6) or inocula (5 X 10(6) cells) depleted of SIg+ cells (10-13 days, n = 5), but additional depletion of cytotoxic T cells and their precursors (OX8+) resulted in marked prolongation of graft survival (n = 4, 4 X 10(6) cells, 45-67 days). Reducing the reconstituting inocula from 4 X 10(6) to 2.5 X 10(6) spleen cells (OX8-, SIg-) prolonged graft survival to that observed in unreconstituted recipients (generally greater than 100 days). Additional studies were performed to define the immunologic basis for prolonged survival of PVG-RT1r1 heart grafts in homozygous PVG recipients. Although lymphoid cells of naive PVG failed to proliferate (stimulation index [SI] 1.01, P = NS) on coculture with irradiated PVG-RT1r1, bulk cultures yielding but weak and variable CTL generation, lymphoid cells from specifically sensitized PVG proliferated (SI 4.25, P less than .001) and generated greater cytotoxic T lymphocyte (CTL) activity (P less than .001) under identical conditions, strongly suggesting, therefore, that prolonged heart graft survival in this strain combination is related to low CTL precursor frequency. Further, though PVG-RT1r1 heart grafts were rejected in 10-12 days (n = 3) by (PVG X WF)F1 recipients, (PVG-RT1r1 X WF)F1----(PVG X WF)F1 heart grafts (RT1Aa disparity) survived greater than 100 days despite an equivalent alloimmune response, and this was shown to correlate with a reduced sensitivity of (PVG-RT1r1 X WF)F1 target cells to lysis by CTL. These data, therefore, strongly suggest that the pivotal role of CTL in the rejection of class-I-disparate heart grafts is, in fact, related to their function in direct cell-mediated cytolysis.
通过过继转移评估了对携带分离的主要组织相容性复合体(MHC)亚区RT1A编码的I类差异的心脏移植物进行排斥反应的细胞需求。用先前经两次连续的PVG-RT1r1皮肤移植致敏的同基因供体的脾细胞选择性地重建经亚致死剂量照射(780拉德)的照射过的PVG-RT1r1心脏移植物的(PVG×WF)F1受体。用10×10⁶未分级的免疫脾细胞重建的受体中,PVG-RT1r1心脏移植物急性排斥(7 - 9天,n = 6),或接种去除SIg⁺细胞的细胞悬液(5×10⁶个细胞)后移植物在10 - 13天排斥(n = 5),但进一步去除细胞毒性T细胞及其前体(OX8⁺)导致移植物存活显著延长(n = 4,4×10⁶个细胞,45 - 67天)。将重建接种物从4×10⁶个脾细胞减少到2.5×10⁶个(OX8⁻,SIg⁻)脾细胞可使移植物存活延长至未重建受体中观察到的水平(通常大于100天)。进行了额外的研究以确定纯合PVG受体中PVG-RT1r1心脏移植物长期存活的免疫基础。尽管未致敏的PVG淋巴细胞与照射过的PVG-RT1r1共培养时未能增殖(刺激指数[SI] 1.01,P = 无显著性差异),大量培养产生的细胞毒性T淋巴细胞(CTL)生成较弱且变化不定,但在相同条件下,经特异性致敏的PVG淋巴细胞增殖(SI 4.25,P <.001)并产生更强的细胞毒性T淋巴细胞(CTL)活性(P <.001),因此强烈表明,在这种品系组合中,心脏移植物的长期存活与低CTL前体频率有关。此外,尽管(PVG×WF)F1受体在10 - 12天内排斥PVG-RT1r1心脏移植物(n = 3),但(PVG-RT1r1×WF)F1→(PVG×WF)F1心脏移植物(RT1Aa差异)尽管同种免疫反应相当,但存活超过100天,并且这被证明与(PVG-RT1r1×WF)F1靶细胞对CTL裂解的敏感性降低相关。因此,这些数据强烈表明CTL在I类不相合心脏移植物排斥中的关键作用实际上与其在直接细胞介导的细胞溶解中的功能有关。